Diabetes & Endocrinology News
- Georgia Ban on Transgender Healthcare Challenged in Lawsuit
- ADA 2023 COORDINATE-Diabetes: a 'Wake-Up Call' for Many Specialties
- ADA 2023 33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells
- Diabetes May Short Circuit Pembrolizumab Benefits in NSCLC
- GLP-1 Agonists Help in Type 2 Diabetes With Liver Cirrhosis
- ADA 2023 Survodutide Impresses in Phase 2 Weight-Loss Trial
- Eli Lilly to Buy Sigilon Therapeutics to Expand Diabetes Treatments
- New ESH Hypertension Guidelines Aim for Simplified Message
- How Physician Chefs Perfect Life-Saving Cuisine
- New Clues to an Old Mystery: Recent Gains in Endometriosis
- Patients With High BMI Fare Better in Head and Neck Cancer
- US Judges Block Bans on Transgender Youth Healthcare
- Alert FDA OKs Pancreatic Islet Cell Therapy for Type 1 Diabetes
- Alert Pfizer-OPKO's Growth Hormone Drug Gets US Approval in Kids
- Ventilatory Efficiency Impaired in Hypertension
- A Tiny Patch May Someday Do Your Patients' Lab Work
- Physicians Accuse Hospital Chain of Fraud and Overbilling
- ILC 2023 Pegozafermin Improves Fibrosis in NASH in Phase 2b Study
- Woman Jailed for Refusing TB Treatment or Isolation
- Pfizer Scraps One Weight Loss Drug